Search for: "Smalls v. Pfizer Inc"
Results 1 - 20
of 89
Sort by Relevance
|
Sort by Date
23 May 2024, 10:40 am
Pfizer Inc., — F.R.D. [read post]
14 Apr 2024, 9:05 pm
In Panuwat, the defendant was an employee of Medivation, Inc., a mid-cap oncology firm that was resisting one hostile bidder (Sanofi S.A.) and encouraging another firm (Pfizer) to outbid Sanofi. [read post]
27 Feb 2024, 7:08 pm
Cir. 2018), Arnold Partnership v. [read post]
9 Jun 2023, 8:36 am
Developing a competitor to Tepezza or Krystexxa would require significant upfront investment by any firm, while the marginal manufacturing and distribution costs, while not insignificant, are small in comparison. [read post]
9 Jun 2023, 8:36 am
Developing a competitor to Tepezza or Krystexxa would require significant upfront investment by any firm, while the marginal manufacturing and distribution costs, while not insignificant, are small in comparison. [read post]
3 Jan 2023, 1:47 pm
The directors’ and officers’ liability environment is always changing, but 2022 was a particularly eventful year, with important consequences for the D&O insurance marketplace. [read post]
17 Oct 2021, 2:17 pm
Kehm v. [read post]
19 Feb 2021, 2:28 am
In its latest decision on this topic, Amgen Inc. et al. v. [read post]
17 Sep 2020, 4:55 am
” It returned the following statement from the case Frlekin v. [read post]
17 Mar 2020, 1:32 pm
Twelve Lots of CHANTIX® (Varenicline) Tablets have been recalled by Pfizer due to N-Nitroso Varenicline content above ADI level. [read post]
13 Aug 2019, 6:03 am
PepsiCo, Inc. regarding whether use of another’s trademark in a marketing slogan is fair use. [read post]
14 May 2019, 11:24 am
Cir. 2009) (quoting Pfizer, Inc. v. [read post]
28 Dec 2018, 9:27 am
Pfizer, Inc., No. 2:18-cv-16083, complaint (D.N.J., Nov. 13, 2018). [read post]
24 Mar 2016, 4:00 am
The Federal Court recently held, in Apotex Inc. v. [read post]
18 Mar 2016, 5:06 am
Pfizer, Inc., which involved a pharmaceutical rep. [read post]
29 May 2015, 8:25 am
The NLDC produced a development plan that would revitalize Fort Trumbull by building housing, office space, and other facilities that would support a new headquarters that Pfizer, Inc. [read post]
14 May 2015, 4:00 am
In Eli Lilly Canada Inc. v. [read post]
25 Apr 2015, 11:03 am
For example, in some litigations, plaintiffs will rely upon high-dose or high-exposure studies that are not comparable to the plaintiff’s actual exposure, and the defense may have shown that the only reliable evidence is that there is a small (relative risk less than two) or no risk at all from the plaintiff’s exposure. [read post]
1 Apr 2015, 4:30 am
Pa. 2012); Steele v. [read post]
30 Jan 2015, 8:19 pm
When the Supreme Court delivered its decision in Matrixx Initiatives, Inc. v. [read post]
